 A STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF ALECTINIB VERSUS CRIZOTINIB AND TO EVALUATE THE PHARMACOKINETICS OF ALECTINIB IN ASIAN PARTICIPANTS WITH TREATMENT-NAIVE ANAPLASTIC LYMPHOMA KINASE ALK-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER NSCLC: 